The fact that drugs are cheaper in Europe does not mean the market there is fairer or more efficient: <a href="https:&#x2F;&#x2F;en.wikipedia.org&#x2F;wiki&#x2F;Monopsony" rel="nofollow">https:&#x2F;&#x2F;en.wikipedia.org&#x2F;wiki&#x2F;Monopsony</a>. European governments have monopsonist power: through negotiating with manufacturers directly, they drive prices below the efficient level.